Related references
Note: Only part of the references are listed.Omega-3 fatty acids, cardiovascular risk, and the resolution of inflammation
Magnus Back et al.
FASEB JOURNAL (2019)
Leukocytes from obese individuals exhibit an impaired SPM signature
Cristina Lopez-Vicario et al.
FASEB JOURNAL (2019)
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
Deepak L. Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
The role of non-resolving inflammation in atherosclerosis
Canan Kasikara et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Pro-resolving lipid mediators in vascular disease
Michael S. Conte et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rabbit vein graft model
Bian Wu et al.
JOURNAL OF VASCULAR SURGERY (2018)
Biosynthesis of proresolving lipid mediators by vascular cells and tissues
Anuran Chatterjee et al.
FASEB JOURNAL (2017)
Maresin 1 induces a novel pro-resolving phenotype in human platelets
K. L. Lannan et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rat model of arterial injury
Bian Wu et al.
JOURNAL OF VASCULAR SURGERY (2017)
Specialized pro-resolving mediators in cardiovascular diseases
Gabrielle Fredman et al.
MOLECULAR ASPECTS OF MEDICINE (2017)
Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors
Nan Chiang et al.
MOLECULAR ASPECTS OF MEDICINE (2017)
Aspirin-triggered lipoxin A4 inhibits atherosclerosis progression in apolipoprotein E-/- mice
Marcelo H. Petri et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Resolution of Acute Inflammation and the Role of Resolvins in Immunity, Thrombosis, and Vascular Biology
Brian E. Sansbury et al.
CIRCULATION RESEARCH (2016)
Resolving Lipid Mediators Maresin 1 and Resolvin D2 Prevent Atheroprogression in Mice
Joana R. Viola et al.
CIRCULATION RESEARCH (2016)
Identification and Actions of the Maresin 1 Metabolome in Infectious Inflammation
Romain A. Colas et al.
JOURNAL OF IMMUNOLOGY (2016)
The role of neutrophils in inflammation resolution
Hefin R. Jones et al.
SEMINARS IN IMMUNOLOGY (2016)
An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques
Gabrielle Fredman et al.
NATURE COMMUNICATIONS (2016)
Elucidation of novel 13-series resolvins that increase with atorvastatin and clear infections
Jesmond Dalli et al.
NATURE MEDICINE (2015)
Short-Term, High-Dose Fish Oil Supplementation Increases the Production of Omega-3 Fatty Acid-Derived Mediators in Patients With Peripheral Artery Disease (the OMEGA-PAD I Trial)
S. Marlene Grenon et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2015)
Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue
Romain A. Colas et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2014)
Inflammation and its Resolution as Determinants of Acute Coronary Syndromes
Peter Libby et al.
CIRCULATION RESEARCH (2014)
Macrophage Polarization in Inflammatory Diseases
Yan-Cun Liu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2014)
Pro-resolving lipid mediators are leads for resolution physiology
Charles N. Serhan
NATURE (2014)
Resolvin D3 and Aspirin-Triggered Resolvin D3 Are Potent Immunoresolvents
Jesmond Dalli et al.
CHEMISTRY & BIOLOGY (2013)
D-series resolvin attenuates vascular smooth muscle cell activation and neointimal hyperplasia following vascular injury
Takuya Miyahara et al.
FASEB JOURNAL (2013)
Human monocyte-derived macrophages spontaneously differentiated in vitro show distinct phenotypes
Sonia Eligini et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis
F. Gerald R. Fowkes et al.
LANCET (2013)
Infection regulates pro-resolving mediators that lower antibiotic requirements
Nan Chiang et al.
NATURE (2012)
Novel Proresolving Aspirin-Triggered DHA Pathway
Charles N. Serhan et al.
CHEMISTRY & BIOLOGY (2011)
Omega-3 Fatty Acids and Cardiovascular Disease Effects on Risk Factors, Molecular Pathways, and Clinical Events
Dariush Mozaffarian et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Aspirin-Triggered Lipoxin and Resolvin E1 Modulate Vascular Smooth Muscle Phenotype and Correlate with Peripheral Atherosclerosis
Karen J. Ho et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Novel Lipid Mediators Promote Resolution of Acute Inflammation Impact of Aspirin and Statins
Matthew Spite et al.
CIRCULATION RESEARCH (2010)
Biomarkers in peripheral arterial disease patients and near- and longer-term mortality
Michael H. Criqui et al.
JOURNAL OF VASCULAR SURGERY (2010)
The Omega-3 Index: Clinical Utility for Therapeutic Intervention
William S. Harris
Current Cardiology Reports (2010)
Metabolic Syndrome, Inflammation, and Risk of Symptomatic Peripheral Artery Disease in Women A Prospective Study
David Conen et al.
CIRCULATION (2009)
The omega-3 index: From biomarker to risk marker to risk factor
William S. Harris
CURRENT ATHEROSCLEROSIS REPORTS (2009)
Biomarkers of inflammation and thrombosis as predictors of near-term mortality in patients with peripheral arterial disease: A cohort study
Himabindu Vidula et al.
ANNALS OF INTERNAL MEDICINE (2008)
Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators
Aksam J. Merched et al.
FASEB JOURNAL (2008)
Biomarkers of inflammation and malnutrition associated with early death in healthy elderly people
Isabelle Carriere et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2008)
Ethnic-specific prevalence of peripheral arterial disease in the United States
Matthew A. Allison et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2007)
Elevated C-reactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgery
Christopher D. Owens et al.
JOURNAL OF VASCULAR SURGERY (2007)
Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised openlabel, blinded endpoint analysis
Mitsuhiro Yokoyama et al.
LANCET (2007)
Augmentation of myocardial production of 15-epi-lipoxin-A4 by pioglitazone and atorvastatin in the rat
Yochai Birnbaum et al.
CIRCULATION (2006)
Comparison of usefulness of inflammatory markers in patients with versus without peripheral arterial disease in predicting adverse cardiovascular outcomes (myocardial infarction, stroke, and death)
JA Beckman et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population - Edinburgh Artery Study
I Tzoulaki et al.
CIRCULATION (2005)
Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution
CN Serhan
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2005)
Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease
PM Kris-Etherton et al.
CIRCULATION (2002)
Novel risk factors for systemic atherosclerosis - A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease
PM Ridker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Cutting edge: Lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages
C Godson et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
